We are involved in a number of joint working projects with various NHS organisations across the country. Find out more about these projects by reading the executive summaries below.
The project is being undertaken to ultimately deliver a collaborative pharmacy and surgery inhaler project, which includes inhaler technique training, medicine use review (MUR) training and other support services.
Title of project: Ashford collaborative pharmacy and surgery inhaler project
Project period: the project will run for seven months but can be extended by agreement of all parties.
Project is designed to:
The project is being undertaken to improve asthma education and to achieve better asthma control for people in the Somali community living in Bristol. The project is taking a novel approach offering tailored support directly to the target community.
Project Period: Both parties have committed resources to the project and the project will run for six months but can be extended by agreement of all parties.
The project is designed to:
The project aims to improve the management of asthma patients by running Advanced Inhaler Training (AIT) modules for healthcare professionals through accredited AIT trainers
Project period: Both parties have committed resources to this project and the project will run for a period of 12 months
Project is designed to:
The project is called PANNASH (Pulmonary Advancement Network for Newark and Sherwood), which aims to enhance care for patients with chronic obstructive pulmonary disease (COPD) in Newark and Sherwood.
Teva UK Limited will be responsible for providing spirometry training and education for healthcare professionals within member practices of Newark and Sherwood CCG.
The training will be implemented by a nurse manager and a nurse trainer from The IMPACT service, (Improving the Management of patients asthma and COPD treatment), and is sponsored by Teva UK Limited and delivered by National Services for Health Improvement, (NSHI).
Expected benefits for patients:
Expected benefits for the NHS include:
Benefits for Teva UK Limited include:
In addition Teva UK Limited can be seen as a credible supporter of the Clinical Commissioning Group strategy and can demonstrate value to Newark and Sherwood CCG.
The project aims to improve asthma management to reduce hospital admissions in NHS Bristol.
Project period: Both parties have committed resources to this project and the project will run for a period of 3 months but can be extended by agreement of all parties.
The project is designed to:
The project is part of the NHS Test Bed Programme, where Teva UK Limited is an approved innovator partner to the NHS Sheffield Test Bed, a project aiming to create the ‘Perfect Patient PAthway' (PEPPA).
The NHS Sheffield Test Bed is an opportunity to evaluate digital healthcare solutions in a real world environment for people with one or more long term conditions, to support whole patient care and support self-management.
The Test Bed initiative recognises that technology is challenging accepted ways of working in healthcare, with devices and apps opening up the potential to place more control in the hands of patients and make health outcomes more transparent for clinicians. In the face of ageing populations and rising healthcare costs, digital technology could enhance the patient and care provider experience while reducing the financial burden of care. The partnership between Teva and the NHS in the Sheffield City region provides a powerful example of the kind of collaboration between industry and healthcare providers which will be increasingly vital within this emerging digital health landscape.
In Sheffield, there are approximately 40,000 people – between seven and eight percent of the population – with three or more long-term conditions. The Test Bed will use digital technology, combined with behavioural science and remote patient support, to help patients with multiple long-term conditions manage their health successfully. Teva’s contribution to the Sheffield Test Bed will focus on initially on asthma, employing digital innovation to help asthma patients manage the chronic condition more effectively.
Project Period: Both parties have committed resources to the project and the project will run for twelve months.
The aims & objectives of the collaboration are to;
The project is being undertaken to ultimately refresh and enhance healthcare professionals' skills in, and knowledge of, inhaler technique in order to ensure optimal patient outcomes from their prescribed respiratory therapy.
Title of project: Refreshing and enhancing healthcare professional skills in, and knowledge of, inhaler technique in order to ensure optimal patient outcomes from their prescribed respiratory therapy.
Project period: Both parties have committed resources to this project and the project will run for seventeen months but can be extended by agreement of all parties.
The project is designed to:
Title of project: STOP IT - Stockport Optimising Inhaler Technique
Project period: Both parties have committed resources to this project and the project will run for a period of 12 months
The project aims to improve the management of asthma and chronic obstructive pulmonary disease (COPD) through supporting a group of healthcare professionals from Stockport CCG to become accredited AIT (Advanced Inhaler Technique) trainers.
Project is designed to:
The Project is being undertaken to improve the clinical management, patient satisfaction and outcomes in adults patients diagnosed with chronic primary headache disorders in the Pan Mersey area. This will be achieved by the implementation and embedding of appropriate local, national and NICE treatment guidelines through the deployment of a clinical therapeutic review.
Project Period: Both Parties have committed resources to this project that will run for a period of 12 months, which can be extended if required and if agreed by all parties.
The Project is designed to:
Expected patient benefits for this Project include:
Expected NHS benefits for this Project include:
Expected Teva benefits for this Project include:
CNS-GB-NP-00016
Date of Preparation: December 2020